SAN DIEGO, May 9, 2017 / — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary Kannaway, LLC, the first hemp lifestyle network to offer phyto-cannabinoid botanical products, is expanding to Europe with the establishment of Kannaway® Europe, expected to be fully operational by Q4 2017. The Company has also announced that Jakub Duda has been appointed as Operations Director of Kannaway® Europe.
Prior to his new role at Kannaway® Europe, Poland-native Duda worked with Kannaway® CEO Blake Schroeder running two successful European businesses that each grossed in excess of $50 million per year.
“We are extremely excited to become the first direct selling company featuring phyto-cannabinoid based products to have operations in Europe and to share our products, culture and mission throughout Europe,” said Kannaway ® CEO Blake Schroeder. “Furthermore, Jakub is an incredible addition to our team and we are confident that his background and passion will help ensure that Kannaway® Europe is a success.”
“I am impressed with Kannaway® and am looking forward to bringing its vision to Europe,” said Duda. “My focus will be on ensuring a great experience for Kannaway® Europe’s Brand Ambassadors, from the time product is ordered until it arrives on each doorstep. I am excited to get the word out about Kannaway® and the immense benefit provided by being part of the Kannaway® team to people throughout Europe.”
Information on how to become a European Kannaway® Brand Ambassador will be made available prior to the Company’s official European launch later this year.
About Kannaway, LLC
Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.